Understanding MS is a free online course to improve your understanding and awareness of MS. More than 39,000 people from 170+ countries have enrolled in the course, with research showing it significantly improves MS-related knowledge, health literacy and confidence in communicating about MS.
MS Australia celebrates the successful outcome of the first round of Incubator Grants 2023, awarding four grants worth $92,565.
New research exploring cutting-edge Artificial Intelligence (AI) technology to better analyse MRI scans of patients with multiple sclerosis (MS) could unlock crucial insights into disease progression and pave the way for improved treatment of people living with the condition.
CEO Rohan Greenland highlights World Brain Day’s significance in promoting brain health and urges our politicians to take more action in supporting the one-in-six Australians affected by neurological and neuromuscular conditions.
MS Australia-supported research shows that Aze, a plant-derived amino acid, can induce changes in protein structure that trigger the immune system to target and damage the protective myelin coating around nerve cells. Further research aims to uncover targeted treatments that can counteract these effects and reduce the impact of MS on affected individuals.
A new research study has explored the experiences of people living with MS around the concept of family planning. The study aimed to understand information needs and where opportunities might be to improve informed decision-making between patients and healthcare professionals to provide better support for people with MS.
Elena Canu, a beloved daughter of Italian immigrants, had a fulfilling career working in Australian television. Having lived with MS for 30 years, Elena found it easy to help a cause close to her heart when writing her Will. Now her caring legacy lives on, funding crucial research and helping those affected by MS.
This opinion piece by MS Australia’s President, Associate Professor Des Graham, was prompted by the recent release of the NDIS interim report, What we have heard report, and MS Australia’s ongoing campaign for improvements to the NDIS to better meet the needs of people living with multiple sclerosis.
MS Australia has partnered with Australian research teams in five successful bids for government funding for research into the Epstein-Barr virus (EBV) in MS, totalling almost $10 million.
